Print Page     Close Window     

Investor Home

Corporate Profile

Apricus is committed to developing novel therapies in areas of high unmet needs. We have disciplined leadership focused on execution and are driving near-term shareholder value through regulatory approval, commercialization and partnering initiatives.

Recent Newsmore >
DateTitle
08/02/17Apricus Biosciences Provides Corporate Update and Second Quarter 2017 Financial Results
Vitaros Drug-Device Human Factor Studies Successfully Completed Vitaros U.S. NDA Final Draft Completed with Re-Submission Expected in Current Quarter Conference Call / Webcast Today, August 2, 2017 at 4:30 p.m. ET SAN DIEGO, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today reported financial results for the second quarter of 2017 and provided a corporate update on its pr... 
07/26/17Apricus Biosciences Announces Corporate Update and Second Quarter 2017 Financial Results Conference Call
SAN DIEGO, July 26, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Apricus’ second quarter 2017 financial results will be released on Wednesday, August 2, 2017 at 4:01 p.m. Eastern Time.  Company management will host a conference call on Wednesday, August 2, 2017 at 4:30 p.m. Eastern Time to discuss the financial results and other recent corporate highlights. To pa... 
05/11/17Apricus Biosciences Provides Corporate Update and First Quarter 2017 Financial Results
Vitaros U.S. NDA Re-Submission Remains on Track for Third Quarter 2017 Vitaros Drug-Device Human Factor Studies Underway Operations Funded Through the Third Quarter of 2018 Conference Call / Webcast Today, May 11, 2017 at 4:30 p.m. ET SAN DIEGO, May 11, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today reported financial results for the first quarter of 2017 and provided a corporat... 
Event Calendarmore >
August 2017?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SMTWTFS
-2-112345
6789101112
13141516171819
20212223242526
27282930315152
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Apricus Biosciences, Inc. posts new information to the site. Just enter your e-mail address and click Submit.

 

© Apricus Biosciences, Inc.